October 2, 2023 By Hand and Email Dennis Giesing dhgiesing@gmail.com Re:Separation Agreement Dear Dennis:Separation Agreement • March 28th, 2024 • Immunome Inc. • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2024 Company IndustryThis letter agreement (“Agreement”) sets forth the agreement concerning the end of your employment with Immunome, Inc. (the “Company”). Payment and provision of the Severance Benefits (defined below) is contingent on your agreement to and compliance with the terms of this Agreement. Terms not defined herein shall have the meaning set forth in the employment offer letter dated March 4, 2021 (the “Employment Agreement”), as applicable.
October 3, 2023 By Hand and Email Purnanand Sarma sarmap97@gmail.com Re:Separation Agreement Dear Sarma:Separation Agreement • March 28th, 2024 • Immunome Inc. • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2024 Company IndustryThis letter agreement (“Agreement”) sets forth the agreement concerning the end of your employment with Immunome, Inc. (the “Company”). Payment and provision of the Severance Benefits (defined below) is contingent on your agreement to and compliance with the terms of this Agreement. Terms not defined herein shall have the meaning set forth in the Amended and Restated Employment Agreement between you and the Company effective as of October 14, 2020 (the “Employment Agreement”), as applicable.
December 21, 2023 By Email Corleen Roche Re: Separation Agreement Dear Corleen:Separation Agreement • December 29th, 2023 • Immunome Inc. • Pharmaceutical preparations
Contract Type FiledDecember 29th, 2023 Company IndustryThis letter agreement (“Agreement”) sets forth the agreement concerning the end of your employment with Immunome, Inc. (the “Company”). Payment and provision of the Severance Benefits (defined below) is contingent on your agreement to and compliance with the terms of this Agreement. Terms not defined herein shall have the meaning set forth in the employment offer letter between you and the Company effective as of March 17, 2021 (the “Employment Agreement”).